Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8527726rdf:typepubmed:Citationlld:pubmed
pubmed-article:8527726lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:8527726lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:8527726lifeskim:mentionsumls-concept:C0019564lld:lifeskim
pubmed-article:8527726lifeskim:mentionsumls-concept:C0022116lld:lifeskim
pubmed-article:8527726lifeskim:mentionsumls-concept:C0133873lld:lifeskim
pubmed-article:8527726lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:8527726lifeskim:mentionsumls-concept:C1519355lld:lifeskim
pubmed-article:8527726lifeskim:mentionsumls-concept:C0815279lld:lifeskim
pubmed-article:8527726pubmed:issue12lld:pubmed
pubmed-article:8527726pubmed:dateCreated1996-1-26lld:pubmed
pubmed-article:8527726pubmed:abstractTextExcessive accumulation of Ca2+ in neurones and glutamate release are involved in neuropathological processes, including ischaemia. We investigated the neuroprotective effects of the Ca2+ channel antagonist, omega-Aga-IVA, in CA1 pyramidal neurones in rat hippocampal slices following an in vitro hypoxic-hypoglycaemic insult. Following this insult, evoked post-synaptic response amplitudes decreased from 3.7 +/- 0.5 mV to 0.6 +/- 0.2 mV and the CA1 neurones appeared dead using a live/dead fluorescence assay with confocal microscopy. Slices treated with 200 nM omega-Aga-IVA had evoked response amplitudes not significantly different from control (3.3 +/- 0.5 mV) and the CA1 neurones appeared viable using the live/dead fluorescence assay. The neuroprotective efficacy of omega-Aga-IVA suggests that omega-Aga-IVA-sensitive Ca2+ channels participate in ischaemic neuronal death and constitute a potential target of therapeutic intervention.lld:pubmed
pubmed-article:8527726pubmed:languageenglld:pubmed
pubmed-article:8527726pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8527726pubmed:citationSubsetIMlld:pubmed
pubmed-article:8527726pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8527726pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8527726pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8527726pubmed:statusMEDLINElld:pubmed
pubmed-article:8527726pubmed:monthAuglld:pubmed
pubmed-article:8527726pubmed:issn0959-4965lld:pubmed
pubmed-article:8527726pubmed:authorpubmed-author:BuchanA MAMlld:pubmed
pubmed-article:8527726pubmed:authorpubmed-author:MonettiNNlld:pubmed
pubmed-article:8527726pubmed:authorpubmed-author:MorleyPPlld:pubmed
pubmed-article:8527726pubmed:authorpubmed-author:SmallD LDLlld:pubmed
pubmed-article:8527726pubmed:authorpubmed-author:MealingGGlld:pubmed
pubmed-article:8527726pubmed:issnTypePrintlld:pubmed
pubmed-article:8527726pubmed:day21lld:pubmed
pubmed-article:8527726pubmed:volume6lld:pubmed
pubmed-article:8527726pubmed:ownerNLMlld:pubmed
pubmed-article:8527726pubmed:authorsCompleteYlld:pubmed
pubmed-article:8527726pubmed:pagination1617-20lld:pubmed
pubmed-article:8527726pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8527726pubmed:meshHeadingpubmed-meshheading:8527726-...lld:pubmed
pubmed-article:8527726pubmed:meshHeadingpubmed-meshheading:8527726-...lld:pubmed
pubmed-article:8527726pubmed:meshHeadingpubmed-meshheading:8527726-...lld:pubmed
pubmed-article:8527726pubmed:meshHeadingpubmed-meshheading:8527726-...lld:pubmed
pubmed-article:8527726pubmed:meshHeadingpubmed-meshheading:8527726-...lld:pubmed
pubmed-article:8527726pubmed:meshHeadingpubmed-meshheading:8527726-...lld:pubmed
pubmed-article:8527726pubmed:meshHeadingpubmed-meshheading:8527726-...lld:pubmed
pubmed-article:8527726pubmed:meshHeadingpubmed-meshheading:8527726-...lld:pubmed
pubmed-article:8527726pubmed:meshHeadingpubmed-meshheading:8527726-...lld:pubmed
pubmed-article:8527726pubmed:meshHeadingpubmed-meshheading:8527726-...lld:pubmed
pubmed-article:8527726pubmed:meshHeadingpubmed-meshheading:8527726-...lld:pubmed
pubmed-article:8527726pubmed:meshHeadingpubmed-meshheading:8527726-...lld:pubmed
pubmed-article:8527726pubmed:year1995lld:pubmed
pubmed-article:8527726pubmed:articleTitleNeuroprotective effects of omega-Aga-IVA against in vitro ischaemia in the rat hippocampal slice.lld:pubmed
pubmed-article:8527726pubmed:affiliationUniversity of Ottawa, Ontario, Canada.lld:pubmed
pubmed-article:8527726pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8527726pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:8527726pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed